Dept. of Clinical Physics and Bio-Engineering, University of Glasgow, Gartnavel Royal Hospital, Glasgow G12 0XH, UK; Task Group 116 member, International Commission on Radiological Protection, 280 Slater Street, Ottawa, Ontario K1P 5S9, Canada.
Dept. of Physical Sciences, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia; Task Group 116 member, International Commission on Radiological Protection, 280 Slater Street, Ottawa, Ontario K1P 5S9, Canada.
Phys Med. 2021 Oct;90:53-65. doi: 10.1016/j.ejmp.2021.09.004. Epub 2021 Sep 22.
Improvements in delivery of radiation dose to target tissues in radiotherapy have increased the need for better image quality and led to a higher frequency of imaging patients. Imaging for treatment planning extends to function and motion assessment and devices are incorporated into medical linear accelerators (linacs) so that regions of tissue can be imaged at time of treatment delivery to ensure dose distributions are delivered as accurately as possible. A survey of imaging in 97 radiotherapy centres in nine countries on six continents has been undertaken with an on-line questionnaire administered through the International Commission on Radiological Protection mentorship programme to provide a snapshot of imaging practices. Responses show that all centres use CT for planning treatments and many utilise additional information from magnetic resonance imaging and positron emission tomography scans. Most centres have kV cone beam CT attached to at least some linacs and use this for the majority of treatment fractions. The imaging options available declined with the human development index (HDI) of the country, and the frequency of imaging during treatment depended more on country than treatment site with countries having lower HDIs imaging less frequently. The country with the lowest HDI had few kV imaging facilities and relied on MV planar imaging intermittently during treatment. Imaging protocols supplied by vendors are used in most centres and under half adapt exposure conditions to individual patients. Recording of patient doses, a knowledge of which is important in optimisation of imaging protocols, was limited primarily to European countries.
放射治疗中对靶组织的放射剂量传递的改进增加了对更好的图像质量的需求,并导致了更频繁的对患者进行成像。治疗计划的成像扩展到功能和运动评估,并且设备被合并到医用线性加速器(linac)中,以便在治疗输送时对组织区域进行成像,以确保尽可能准确地输送剂量分布。通过国际放射防护委员会指导计划的在线问卷调查,对六大洲九个国家的 97 个放疗中心的成像情况进行了调查,以了解成像实践的概况。调查结果显示,所有中心都使用 CT 进行治疗计划,许多中心还利用磁共振成像和正电子发射断层扫描的额外信息。大多数中心都至少在一些 linacs 上配备了千伏锥形束 CT,并将其用于大多数治疗部分。成像选项随国家人类发展指数(HDI)的降低而减少,治疗期间的成像频率更多地取决于国家而不是治疗部位,HDI 较低的国家成像频率较低。HDI 最低的国家几乎没有千伏成像设施,并且在治疗期间间歇性地依赖 MV 平面成像。大多数中心都使用供应商提供的成像协议,并且只有不到一半的中心根据个体患者的情况来调整曝光条件。患者剂量的记录,这对于成像协议的优化很重要,主要限于欧洲国家。